TMCnet News
Adverum Biotechnologies to Participate in the Cantor Virtual Global Healthcare ConferenceREDWOOD CITY, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that the company will present at the Cantor Virtual Global Healthcare Conference on Tuesday, September 15, 2020 at 1:00 pm PT. A live webcast will be accessible under Events and Presentations in the Investors section of the company’s website. The archived webcast will be available on the Adverum website following the presentation for 30 days. About Adverum Biotechnologies Investor and Media Inquiries: Investors: Media: |